Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-24-073929
Filing Date
2024-03-21
Accepted
2024-03-21 16:48:09
Documents
17
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d801593d10ka.htm   iXBRL 10-K/A 215123
2 EX-31.1 d801593dex311.htm EX-31.1 3533
3 EX-31.2 d801593dex312.htm EX-31.2 3526
  Complete submission text file 0001193125-24-073929.txt   458313

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA mack-20231231.xsd EX-101.SCH 4575
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mack-20231231_cal.xml EX-101.CAL 657
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mack-20231231_def.xml EX-101.DEF 17155
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE mack-20231231_lab.xml EX-101.LAB 22758
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mack-20231231_pre.xml EX-101.PRE 18268
21 EXTRACTED XBRL INSTANCE DOCUMENT d801593d10ka_htm.xml XML 7627
Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617-441-1000
MERRIMACK PHARMACEUTICALS INC (Filer) CIK: 0001274792 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-35409 | Film No.: 24772025
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)